What this test measures
- Apolipoprotein B (ApoB)From the lab
One of these proteins sits on every particle that can lodge in an artery wall, so this counts those particles directly.
An ApoB test counts the particles in your blood that can carry cholesterol into an artery wall. Each of those particles carries one molecule of apolipoprotein B, so the result is a direct count of particles rather than a measure of the cholesterol inside them. That is why cardiology guidelines treat ApoB as a sharper reading of the same risk that LDL cholesterol is meant to show.
What ApoB measures
Cholesterol and triglycerides do not dissolve in blood. They travel inside lipoproteins, small particles with a protein coat. LDL, VLDL, IDL and lipoprotein(a) all carry apolipoprotein B on that coat, and each particle carries a single ApoB molecule. Measuring ApoB therefore estimates how many of these atherogenic, or plaque-forming, particles are in circulation.
A standard LDL result measures something else: how much cholesterol sits in the LDL fraction. When particles are small and each carries little cholesterol, LDL cholesterol can look ordinary while the particle count is high. The 2019 European guideline on dyslipidaemia notes that calculated LDL can underestimate risk in people with high triglycerides, diabetes, obesity or very low LDL, and recommends ApoB in those groups. The 2026 US guideline takes a similar line: once LDL and non-HDL cholesterol goals are met, ApoB can be used to look for remaining risk in people with type 2 diabetes, high triglycerides, cardiovascular-kidney-metabolic syndrome or known heart disease, where it may be a more accurate marker than LDL.
ApoB normal range
ApoB is reported in grams per litre (g/L), the SI unit European bodies recommend for apolipoproteins, or in milligrams per decilitre (mg/dL). To convert, multiply g/L by 100. There is no single normal value, because the right number depends on a person's overall cardiovascular risk. These are the reference points most reports and guidelines use:
| ApoB | g/L | mg/dL | Source |
|---|---|---|---|
| Flagged on lab reports as above the desirable level | 1.0 or above | 100 or above | EAS and EFLM joint consensus |
| Goal for people at moderate risk | below 1.0 | below 100 | ESC/EAS 2019 |
| Goal for people at high risk | below 0.8 | below 80 | ESC/EAS 2019 |
| Goal for people at very high risk | below 0.65 | below 65 | ESC/EAS 2019 |
Some laboratories print a population reference interval instead, which can be as wide as about 0.5 to 1.5 g/L (50 to 150 mg/dL). That band describes where most people fall, not where risk is lowest. Ranges also vary by laboratory, method, age and sex, and the range on your own report is the one to read your result against.
What a high ApoB usually points to
A high ApoB means more particles that can lodge in artery walls. It is a risk marker, not a diagnosis. It usually reflects one of a few patterns: raised LDL cholesterol, raised triglycerides carried on many small particles, or an inherited lipid disorder.
A doctor reading a high result will usually set it next to LDL cholesterol, non-HDL cholesterol, triglycerides and lipoprotein(a), then look at the wider picture: blood pressure, smoking, blood sugar and family history. Before referring anyone to a specialist, NICE advises ruling out common secondary causes of abnormal lipids, including an underactive thyroid, uncontrolled diabetes, liver disease, nephrotic syndrome (a kidney condition that leaks protein) and heavy drinking. That is why TSH, HbA1c and liver and kidney tests often sit beside a lipid result.
What a low ApoB usually points to
A low ApoB means fewer of these particles, which is the direction cholesterol guidelines aim for. ApoB also falls on cholesterol-lowering treatment, which is why the European guideline uses it as a treatment goal. Very low values are uncommon. One inherited cause is familial hypobetalipoproteinaemia, thought to affect about 1 in 1,000 to 3,000 people, which can come with a fatty liver and difficulty absorbing fat. A very low result is worth raising with a doctor, who can judge whether it needs a closer look.
What moves ApoB
- Weight and smoking. In a Swedish cohort of 24,984 adults, a higher body mass index and smoking were the main lifestyle factors linked to a higher ApoB.
- Food. In the same cohort, more sucrose and sugar-sweetened foods went with a higher ApoB. A single meal hardly matters: a joint European consensus found ApoB is not affected by whether you have eaten.
- Pregnancy. ApoB rises through pregnancy, by about 56% by the third trimester in one cohort, and lipids return towards pre-pregnancy levels after delivery.
- Other conditions. An underactive thyroid, uncontrolled diabetes, liver disease and nephrotic syndrome can all disturb lipids.
- Medicines. Cholesterol-lowering medicines lower ApoB. If you take one, the result is read against treatment goals rather than population bands.
- Units. Check whether a report uses g/L or mg/dL before comparing it with an earlier result.
Preparing for an ApoB test
ApoB on its own does not need fasting. The European consensus on lipid testing found no difference in ApoB between fasting and non-fasting samples. In a panel that also includes fasting glucose and fasting insulin, the sample is taken after a fast anyway, which does this result no harm. Water is allowed. Tell the person taking the sample about any cholesterol-lowering medicine, a recent illness or a pregnancy.
How Clare's panel handles ApoB
In Clare's panel, ApoB is measured by the lab. The panel also includes LDL cholesterol, non-HDL cholesterol and triglycerides, so the particle count and the cholesterol count come from the same sample and can be compared directly. Clare also uses it to calculate the ApoB / ApoA1 ratio, which is ApoB divided by ApoA1.
Why it matters in the UAE
The clearest regional data come from INTERHEART, a study of heart attacks in 52 countries. Its Middle East arm compared 1,364 people who had just had their initial heart attack with 1,525 matched controls in eight countries, the UAE among them. A raised ratio of ApoB to ApoA1 had the strongest link with heart attack of the nine risk factors studied there, and the average age at that heart attack was 51.2, younger than in any other INTERHEART region. That is a ratio rather than ApoB alone, but ApoB is its upper half.
ApoB test price in the UAE
When we read public prices on 11 October 2026, an ApoB test on its own cost from 75 to 145 at two UAE providers. Neither page stated VAT, and home collection can add a fee: one of the two charged for a home visit on smaller orders. ApoB also appears inside some broader lipid packages.
Related tests
ApoB is usually read with LDL Cholesterol, Non-HDL Cholesterol and Lipoprotein(a). For more on why the particle count and the cholesterol count can disagree, read ApoB: the cholesterol number most UAE panels skip.
Why ApoB means more over time
MedlinePlus advises repeating lipid tests every five years when results are normal, and more often with diabetes, high blood pressure or heart disease, or on cholesterol-lowering treatment. ApoB fits the same rhythm. An initial result sets a baseline; a later one, measured the same way, shows whether the particle count moved after a change in weight, diet or treatment, and that direction says more than either number alone. Clare is opening with a waitlist at clare.health.
- ESC/EAS, 2019 Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, European Heart Journal (2020) https://academic.oup.com/eurheartj/article/41/1/111/5556353
- American College of Cardiology, ACC/AHA release new clinical guideline for managing dyslipidemia (2026) https://www.acc.org/latest-in-cardiology/journal-scans/2026/03/13/15/20/acc-aha-release-new-clinical-guideline-for-managing-dyslipidemia
- Nordestgaard et al., Fasting is not routinely required for determination of a lipid profile: joint consensus statement from the EAS and EFLM, European Heart Journal (2016) https://pmc.ncbi.nlm.nih.gov/articles/PMC4929379/
- MedlinePlus (US National Library of Medicine), Apolipoprotein B (reviewed 2026) https://medlineplus.gov/ency/article/003502.htm
- MedlinePlus (US National Library of Medicine), Cholesterol testing and results (reviewed 2026) https://medlineplus.gov/ency/patientinstructions/000386.htm
- NICE, NG238 Cardiovascular disease: risk assessment and reduction, including lipid modification (2023) https://www.nice.org.uk/guidance/ng238/chapter/Recommendations
- Frondelius et al., Lifestyle and dietary determinants of serum apolipoprotein A1 and apolipoprotein B concentrations: a Swedish cohort of 24,984 individuals, Nutrients (2017) https://pmc.ncbi.nlm.nih.gov/articles/PMC5372874/
- Wild and Feingold, Effect of pregnancy on lipid metabolism and lipoprotein levels, Endotext, NCBI Bookshelf (updated 2026) https://www.ncbi.nlm.nih.gov/books/NBK498654/
- MedlinePlus Genetics (US National Library of Medicine), Familial hypobetalipoproteinemia https://medlineplus.gov/genetics/condition/familial-hypobetalipoproteinemia/
- Gehani et al., Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study, European Journal of Preventive Cardiology (2014) https://pubmed.ncbi.nlm.nih.gov/23125402/
- Dugani et al., Premature myocardial infarction in the Middle East and North Africa: rationale for the Gulf PREVENT study, Angiology (2020) https://pmc.ncbi.nlm.nih.gov/articles/PMC6878147/
- Intel Lab, Apolipoprotein B (Apo B), price read 11 October 2026 https://intel-lab.ae/biomarkers/apolipoprotein-b-apo-b
- Unilabs, Apolipoprotein B, price read 11 October 2026 https://ae.unilabs.online/medical-tests/apolipoprotein-b
Last updated